Fundz

Strata Critical Medical

New York, New York, United States · Biotechnology, Health Care, Information Technology

Strata Critical Medical, Inc. is a Delaware-based medical technology firm. The company focuses on developing innovative solutions in the healthcare sector. Strata specializes in critical care and advanced medical devices. They aim to enhance patient outcomes through cutting-edge technology.

Key facts

Headquarters
New York, New York, United States
Employees
501
Industries
Biotechnology, Health Care, Information Technology
Status
Public (SRTA)
Website
stratamedical.com
LinkedIn
Company page

Recent activity at Strata Critical Medical

  • : Strata Critical acquires Keystone for growth
  • : Strata Critical Medical completes three acquisitions
  • : SEC 8-K (2.02): On March 3, 2026, Strata Critical Medical, Inc. announced its financial results for the fourth quarter ending December 31, 2025. The announcement includes key performance metrics that reflect the company's financial condition and operational results during this period. The results were disclosed in a press release, which has been furnished as Exhibit 99.1 to the current report. This financial disclosure is significant for investors and reflects the company's ongoing business health and strategic direction for the future.
  • : SEC 8-K (1.01): On January 30, 2026, Strata Critical Medical, Inc. and its subsidiaries entered into a Credit Agreement with JPMorgan Chase Bank, providing for secured, asset-based revolving credit loans totaling up to $30.0 million. The Credit Agreement can be increased by an additional $20.0 million under certain conditions. The loan is guaranteed by Strata and its subsidiaries, secured by first priority liens on personal property, and matures on January 30, 2029. The interest rates can be fixed or floating, with a margin of 2.00%, and the funds are designated for working capital and organizational purposes. This agreement enhances the financial resources available to the Company, positioning it for future growth.
  • : SEC 8-K (5.02): On December 2, 2025, Strata Critical Medical, Inc. expanded its board of directors from eight to nine members by appointing William L. Cook, III as a Class I director, effective immediately, with his term expiring at the Company's 2027 annual meeting of stockholders. Mr. Cook was determined to be independent under Nasdaq rules and will serve on both the Compensation Committee and the Nominating and Corporate Governance Committee. He was granted 33,157 restricted stock units that will vest at the 2027 annual meeting, alongside standard indemnification agreements. The Company also disclosed in a press release on December 3, 2025, about Mr. Cook's appointment, reaffirming the strategic alignment with governance guidelines.
  • : SEC 8-K (5.02): On December 2, 2025, Strata Critical Medical, Inc. expanded its board of directors from eight to nine members by appointing William L. Cook, III as a Class I director. His term will expire at the Company’s 2027 annual meeting of stockholders. The Board determined Mr. Cook to be independent under Nasdaq Capital Market rules, enhancing the governance of the Company. This change may signify a strategic move to strengthen the board’s oversight and expertise.

Dates are the day the event happened, taken from the announcement or SEC filing, unless a row says otherwise.

Strata Critical Medical in the news

Companies similar to Strata Critical Medical

  • AP Technologies · Biotechnology, Health Care, Information Technology, Manufacturing, Medical, Medical Device
  • Nusano · Biotechnology, Health Care, Information Technology, Manufacturing, Medical, Medical Device
  • MedShift · Biotechnology, Health Care, Information Technology, Manufacturing, Medical, Medical Device
  • RADNOSTIX · Biotechnology, Health Care, Information Technology, Manufacturing, Medical, Medical Device
  • QTREX Quantum Ltd · Biotechnology, Health Care, Information Technology, Manufacturing, Medical, Medical Device

About Strata Critical Medical: questions and answers

What does Strata Critical Medical do?

Strata Critical Medical, Inc. is a Delaware-based medical technology firm. The company focuses on developing innovative solutions in the healthcare sector. Strata specializes in critical care and advanced medical devices. They aim to enhance patient outcomes through cutting-edge technology.

Where is Strata Critical Medical headquartered?

Strata Critical Medical is headquartered in New York, New York, United States.

How many employees does Strata Critical Medical have?

Strata Critical Medical has about 501 employees.

What is the latest news on Strata Critical Medical?

On Sep 8, 2026, Strata Critical acquires Keystone for growth

Is Strata Critical Medical a public company?

Yes. Strata Critical Medical is publicly traded under the ticker SRTA.

Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy

Fundz watches Strata Critical Medical across 18 signal types, from funding and M&A to exec moves and hiring.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.